• LAST PRICE
    5.6000
  • TODAY'S CHANGE (%)
    Trending Up0.0400 (0.7194%)
  • Bid / Lots
    5.5300/ 10
  • Ask / Lots
    5.6400/ 35
  • Open / Previous Close
    5.5800 / 5.5600
  • Day Range
    Low 5.5600
    High 5.6000
  • 52 Week Range
    Low 2.6063
    High 5.6500
  • Volume
    247,203
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 5.56
TimeVolumeALIM
09:32 ET23715.58
09:36 ET1105.58
09:38 ET3215.57
09:41 ET1005.56
09:45 ET7025.57
09:48 ET3005.565
09:54 ET21305.565
09:56 ET6045.57
10:01 ET5915.57
10:03 ET19825.57
10:08 ET1005.565
10:17 ET1005.57
10:19 ET4005.5601
10:24 ET1005.57
10:26 ET1005.57
10:30 ET254125.57
10:32 ET10005.57
10:33 ET6005.57
10:35 ET6355.57
10:37 ET2545.57
10:39 ET14515.575
10:42 ET5005.58
10:44 ET305745.58
10:46 ET7315.58
10:48 ET33835.58
10:50 ET8325.57
10:51 ET1155.58
10:53 ET1005.58
10:55 ET5475.58
10:57 ET3855.58
11:00 ET1005.575
11:02 ET2005.575
11:04 ET5955.575
11:06 ET3125.575
11:08 ET3905.58
11:09 ET3005.58
11:11 ET3005.58
11:18 ET1005.575
11:20 ET7005.575
11:22 ET2005.575
11:24 ET1125.575
11:26 ET4485.575
11:27 ET1005.575
11:31 ET4005.575
11:42 ET3905.57
11:44 ET1005.575
11:45 ET2035.57
11:58 ET101215.57
12:00 ET17005.565
12:02 ET3005.565
12:03 ET76905.57
12:12 ET28005.57
12:14 ET3005.57
12:16 ET11185.565
12:39 ET1455.57
12:48 ET90825.5799
12:50 ET4655.57
01:17 ET1005.58
01:19 ET5005.58
01:32 ET1005.57
01:37 ET3005.58
01:44 ET1005.575
01:46 ET1005.575
02:00 ET3205.58
02:02 ET3005.575
02:36 ET10005.5703
02:38 ET2005.58
03:00 ET1005.58
03:02 ET6415.58
03:03 ET1005.58
03:09 ET6225.574
03:16 ET2005.575
03:18 ET2565.58
03:21 ET1045.58
03:25 ET3005.58
03:27 ET12005.58
03:30 ET13655.58
03:32 ET34925.58
03:34 ET12005.58
03:36 ET17005.58
03:38 ET12005.58
03:39 ET13005.58
03:41 ET18005.58
03:43 ET64265.58
03:45 ET141965.58
03:48 ET69565.575
03:50 ET38685.58
03:52 ET68945.58
03:54 ET69325.58
03:56 ET125265.58
03:57 ET78415.6
03:59 ET62995.6
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALIM
Alimera Sciences Inc
293.4M
-3.6x
---
United StatesENTA
Enanta Pharmaceuticals Inc
338.9M
-2.6x
---
United StatesNKTR
Nektar Therapeutics
260.7M
-1.5x
---
United StatesCDXC
Chromadex Corp
197.2M
-55.5x
---
United StatesGTHX
G1 Therapeutics Inc
166.8M
-5.2x
---
United StatesCDXS
Codexis Inc
225.8M
-3.4x
---
As of 2024-07-13

Company Information

Alimera Sciences, Inc. is a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic retinal pharmaceuticals. It is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. ILUVIEN is an intravitreal implant that treats patients by delivering a continuous micro dose of the corticosteroid fluocinolone acetonide (FAc) in the eye, for up to 36 months. ILUVIEN is inserted into the back of the patient's eye in a non-surgical procedure employing a device with a 25-gauge needle, which allows for a self-sealing wound. DME is also treated by laser photocoagulation, a retinal procedure in which a laser is used to apply a burn.

Contact Information

Headquarters
STE 290, 6120 WINDWARD PARKWAYALPHARETTA, GA, United States 30005
Phone
678-990-5740
Fax
678-990-5744

Executives

Non-Executive Chairman of the Board
C. Daniel Myers
President, Chief Executive Officer, Director
Richard Eiswirth
Chief Financial Officer
Elliot Maltz
President - International Operations
Philip Ashman
Chief Operating Officer, Director
Jason Werner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$293.4M
Revenue (TTM)
$90.2M
Shares Outstanding
52.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.28
EPS
$-1.57
Book Value
$0.88
P/E Ratio
-3.6x
Price/Sales (TTM)
3.3
Price/Cash Flow (TTM)
---
Operating Margin
-2.23%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.